IUHSA
SCLN

Itau Unibanco Holding S.A.’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,040
Closed -$11K – 579
2016
Q3 		$11K Buy
+1,040
New +$11.3K ﹤0.01% 294

Other funds holding SCLN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Itau Unibanco Holding S.A.'s SCLN Position: Q4 2016 in Review

Itau Unibanco Holding S.A. sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2016, closing a stake of 1,040 shares — an estimated $11K sold.

Itau Unibanco Holding S.A. first reported a position in SCLN in Q3 2016 and held it in 1 quarter. The position peaked at $11K in Q3 2016. 153 funds tracked by Wall St. Rank hold SCLN as of Q4 2016.

  • Itau Unibanco Holding S.A. reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 1,040 Sciclone Pharmaceuticals Inc shares in Q4 2016, an estimated $11K.
  • Itau Unibanco Holding S.A. first reported a position in Sciclone Pharmaceuticals Inc in Q3 2016 and held it in 1 quarter.
  • Itau Unibanco Holding S.A.'s Sciclone Pharmaceuticals Inc position peaked at $11K in Q3 2016.
  • 153 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2016.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2016, filed 14 Feb 2017.